A Comparative Study of Plastic and Conserving Surgery in Surgical Treatment for Breast Cancer

Muhammad Abbas *

1st Affiliated Hospital of Hebei North University, Hebei Province, China.

LI Shu Guang

1st Affiliated Hospital of Hebei North University, Hebei Province, China.

Fu Zhi Jun

1st Affiliated Hospital of Hebei North University, Hebei Province, China.

Wu Wen Long

1st Affiliated Hospital of Hebei North University, Hebei Province, China.

Zeeshan Bashir

Portiuncula University Hospital, Republic of Ireland.

Shahid Moin Qureshi

Hebei Medical University, Hebei Province, China.

*Author to whom correspondence should be addressed.


Abstract

Objective: Tumor surgeons now pay special attention to the alteration in breast form following breast-conserving surgery. Safety of breast-conserving margins and postoperative breast appearance are typically challenging in conventional breast-conserving surgery due to the effect of variables such as big breast tumors or unusual placements. It's important to remember that postoperative breast deformity is a real possibility. Breast-conserving tumor plastic surgery combines tumor excision with plastic surgery, allowing for a more thorough removal of the tumor. It provides a more humane treatment option for the majority of patients by ensuring the safety of surgical margins, considering the aesthetic effects, increasing the breast-conserving opportunities for patients with tumors in special parts, and expanding the indications for breast-conserving surgery. It also greatly improves the postoperative quality of life and mental state. In this article, we deeply examine the current state of knowledge concerning the effectiveness, safety, and appropriate patient population for breast-conserving surgery in the context of tumor plastic surgery.

Keywords: General surgery, plastic surgery, breast neoplasms


How to Cite

Abbas, Muhammad, LI Shu Guang, Fu Zhi Jun, Wu Wen Long, Zeeshan Bashir, and Shahid Moin Qureshi. 2023. “A Comparative Study of Plastic and Conserving Surgery in Surgical Treatment for Breast Cancer”. Journal of Pharmaceutical Research International 35 (6):24-30. https://doi.org/10.9734/jpri/2023/v35i67331.

Downloads

Download data is not yet available.